Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer Dr D Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation Cannabinoids: a new hope for breast cancer therapy?